Amoxicillin-Clavulanate Safety in Pregnancy
Amoxicillin-clavulanate is safe for use during pregnancy and is classified as FDA Pregnancy Category B, with no evidence of teratogenicity in humans. 1
Safety Profile
The FDA drug label explicitly states that reproduction studies in pregnant rats and mice at doses up to 1200 mg/kg/day (4 times the maximum human dose for amoxicillin, 9 times for clavulanate) revealed no evidence of fetal harm 1. While no adequate well-controlled studies exist in pregnant women, the available human data strongly support safety.
Multiple guidelines and large-scale studies confirm compatibility with pregnancy:
- The 2020 ERS/TSANZ respiratory guidelines classify amoxicillin-clavulanate as "Compatible" (B1/FDA B) for use during pregnancy 2
- The 2024 AGA gastroenterology guidelines state that "amoxicillin-clavulanic acid is safe and can be administered during pregnancy" 3
- A 2019 population-based cohort study of 101,615 pregnancies (6,041 exposed to amoxicillin-clavulanate) found no association with major congenital malformations (adjusted RR 1.09,95% CI 0.98-1.20) 4
- A 2004 prospective controlled study of 191 first-trimester exposures showed malformation rates of 1.9% versus 3% in controls (not statistically different) 5
Important Caveats
Avoid in women at risk of preterm delivery: The ERS/TSANZ guidelines note a very low but documented risk of necrotizing enterocolitis in fetuses when amoxicillin-clavulanate is used in women at risk of preterm delivery 2. This is the primary clinical restriction.
Theoretical oral cleft concern: There is mention of a very low risk of oral clefts with exposure during organogenesis, though this risk is minimal and not consistently demonstrated across studies 2, 6.
Recommended Dosing
Standard adult dosing applies during pregnancy:
- 500 mg/125 mg orally three times daily for most infections
- 875 mg/125 mg orally twice daily for more severe infections
- Duration: 7-10 days depending on infection type
The FDA label notes that oral ampicillin-class antibiotics are poorly absorbed during labor, but this does not contraindicate use 1.
Clinical Application Algorithm
- Assess preterm delivery risk: If patient has risk factors for preterm delivery (cervical insufficiency, prior preterm birth, multiple gestation with complications), choose an alternative antibiotic
- If no preterm risk: Amoxicillin-clavulanate can be used safely throughout all trimesters
- Standard dosing applies: No dose adjustment needed for pregnancy
- Duration: Complete full course as indicated for the specific infection
Breastfeeding
Amoxicillin is excreted in breast milk and may lead to infant sensitization, but amoxicillin-clavulanate is generally considered compatible with breastfeeding with appropriate monitoring 1, 2.
The evidence overwhelmingly supports the safety of amoxicillin-clavulanate in pregnancy, with the single critical exception being avoidance in women at risk for preterm delivery due to the rare but serious risk of neonatal necrotizing enterocolitis.